Immunovant, Inc. — SC 13G Filings
6 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Immunovant, Inc. (IMVT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Immunovant, Inc. has filed 6 SC 13G documents with the SEC since 2019. To view all SEC filings by Immunovant, Inc., see the full filings list.
All
10-K
10-Q
144
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS EX
PRE 14A
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000315066-24-001220 | Feb 9, 2024 | — |
| SC 13G | — | 0001172661-22-000395 | Feb 11, 2022 | — |
| SC 13G | — | 0001493152-19-015208 | Oct 8, 2019 | — |
| SC 13G | SCHEDULE 13G | 0000950142-19-001128 | May 22, 2019 | — |
| SC 13G | — | 0000929638-19-000540 | May 20, 2019 | — |
| SC 13G | HEALTH SCIENCES ACQUISITIONS CORPORATION | 0000902664-19-002435 | May 20, 2019 | — |